News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Niklas Klümper: Pre-treatment metastatic biopsy for urothelial cancer
Niklas Klümper
Oct 31, 2024, 15:03

Niklas Klümper: Pre-treatment metastatic biopsy for urothelial cancer

Niklas Klümper, Resident in Urology and Researcher at the Institute for Experimental Oncology at the University Hospital Bonn, shared a post on X about a recent paper by him, published in Nature Reviews Urology.

“Thrilled to share our review published today in Nature Reviews Urology!

‘Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer’.

Thanks to the amazing team of collaborators.

We are exploring how real-time biopsies of metastases could capture the heterogeneity of met. UC, which could provide a clearer path to effective, targeted treatments for mUC!”

“Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer”

Authors: Niklas Klümper, Alexander Cox, Gottfrid Sjödahl, Florian Roghmann, Viktor Grünwald, Bishoy Faltas, Michael Hölzel, Markus Eckstein.

Niklas Klümper: Pre-treatment metastatic biopsy for urothelial cancer

Bishoy Faltas, Chief Research Officer at The Englander Institute for Precision Medicine, shared this post, adding:

“Excited to be part of this exciting review at Nature Reviews Urology.

‘Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer’ with Niklas Klümper, Alexander Cox, Gottfrid Sjödahl, Florian Roghmann, Viktor Grünwald, Michael Hölzel, Markus Eckstein.”

More posts featuring Niklas Klümper.

Alexander Cox Bishoy Faltas cancer Florian Roghmann Gottfrid Sjödahl Markus Eckstein Michael Hölzel Nature Reviews Urology Niklas Klümper OncoDaily Oncology Precision Oncology urothelial cancer Viktor Grünwald
Special Coverage
Blog
Oct 31, 2024, 17:32
Douglas Flora: GRAIL’s Galleri Test’s Credibility and Ethical Conduct
Blog
Oct 31, 2024, 17:31
London Global Cancer Week 2024 - SIOG Session: Putting the older patients first
Blog
Oct 31, 2024, 17:27
Uncovering how pancreatic cancer cells evade the immune system - Cancer Research Institute
Blog
Oct 31, 2024, 17:21
Arturo LoAIza-Bonilla: Excited to Join the Conversation at Google’s AI in Oncology Summit
Blog
Oct 31, 2024, 17:20
How do you navigate lung cancer diagnosis and get involved in patient advocacy? - Oncogene Cancer Research
Blog
Oct 31, 2024, 17:16
Monica Steigerwald: Gilead Sciences announced its amazing allocation of $3.15 million to 22 organizations
Blog
Oct 31, 2024, 17:06
Douglas Flora: Raising awareness and supporting those impacted by blood cancer
Blog
Oct 31, 2024, 17:06
Sarah Louden: The latest insights and breakthroughs from the ESMO USA East meeting
Blog
Oct 31, 2024, 17:03
Sachin Jain: Why a lawsuit over star ratings is one of the proudest achievements of my career
Blog
Oct 31, 2024, 17:01
Gate2Brain has reached a major milestone as its innovative drug, G2B-002, has received Orphan Drug Designation
Blog
Oct 31, 2024, 16:55
Innocent H. Peter Uggh: Ways we could improve our workforce’s mental health, wellbeing and resilience in LMICs
Blog
Oct 31, 2024, 16:52
Ulrika Årehed Kågström: Working towards a future where quality cancer care is available to everyone, everywhere